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Abstract 
Background: The hippocampal formation has been studied extensively in schizophrenic 
psychoses and alterations in hippocampal anatomy have been consistently reported. 
Chronic schizophrenia seems to be associated with bilateral hippocampal volume (HV) 
reduction, while in patients with an at-risk mental state (ARMS) there are contradictory 
results. This is the first region of interest (ROI) based follow-up MRI study of 
hippocampal volume comparing ARMS individuals with and without transition to 
psychosis. The aim was to investigate the timing of HV changes in ARMS in the early 
phase of psychosis. 
Methods: Magnetic resonance imaging data from 18 antipsychotic-naïve individuals with 
an ARMS were collected within the FePsy-clinic for early detection of psychoses. During 
follow-up 8 subjects developed psychosis (ARMS-T) and 10 did not (ARMS-NT). 
Subjects were re-scanned after the onset of psychosis or at the end of the follow-up if they 
did not develop psychosis. 
Results: Across both groups there was a significant decrease in HV over time (p < 0.05). 
There was no significant difference in progression between ARMS-T and ARMS-NT. 
Antipsychotic medication at follow up was associated with increased HV (p < 0.05). 
Conclusions: We found a decrease of HV over time in subjects with an ARMS, 
independently of clinical outcome. Our findings suggest that hippocampal volume 
alterations accumulate during the transition to psychosis, reflecting brain degeneration, and 
potentially allow for the accurate early recognition of individuals at risk of developing 
psychosis. 
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Background 
Over the past decade, research on the prodromal phase of psychosis has exponentially 
progressed, allowing for preventive therapeutic interventions in clinical psychiatry (Fusar-
Poli et al., 2012b). Because it is difficult to predict which subjects with an at-risk mental 
state (ARMS) will later develop psychosis on the basis of their presenting clinical features, 
there is a need for cognitive (Fusar-Poli et al., 2012c) and neurobiological markers to 
identify the individuals at highest risk of developing florid psychosis and those who might 
benefit most from preventive interventions (Fusar-Poli et al., 2012c). ARMS have about 
18%-36% risk of developing psychosis after 6 months to 3 years (Fusar-Poli and Yung, 
2012). In recent years, a range of neuroimaging techniques showed alterations in brain 
structure (Mechelli et al., 2011), function (Fusar-Poli et al., 2007a), and neurochemistry 
(Howes et al., 2007) in the prodromal phase of psychosis (Borgwardt et al., 2011). These 
neuroimaging studies have shown that alterations in brain anatomy and neurophysiology 
found in established psychosis are also present in people with an ARMS (Smieskova et al., 
2010). Overall, ARMS subjects show qualitatively similar, but less pronounced, structural 
brain abnormalities than patients with established schizophrenia. Studies comparing 
ARMS subjects showed reduced gray matter (GM) in prefrontal, temporal and cingulate 
regions, insula, and cerebellum in those subjects who develop psychosis (Fusar-Poli et al., 
2011a). Interestingly, similar areas were also recently found to be related to the duration of 
the ARMS (Smieskova et al., 2011)and to schizotypal personality, a subclinical 
schizophrenia spectrum trait (Ettinger et al., 2011).  
The hippocampal formation has been studied extensively in schizophrenic psychoses, and 
structural and functional changes in hippocampal formation have been reported 
consistently (Adriano et al., 2011, Shenton et al., 2001, Tamminga et al., 2010). The 
integrity of the hippocampal formation is important for declarative memory. The 
significance of hippocampal damage was studied in patients with schizophrenic psychoses 
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and there is growing evidence for association between dysfunction of the hippocampus and 
manifestations of schizophrenic psychoses (Heckers, 2001, Olincy et al., 2006, Preston et 
al., 2005).  
Cross-sectional voxel-based morphometry (VBM) studies of ARMS showed reduced gray 
matter volume in the frontal lobe and medial temporal regions when compared to healthy 
controls (HC), regardless of outcome (Mechelli et al., 2011). In addition, relative to those 
subjects who did not develop the illness, those who later became psychotic showed further 
reduced volumes in particular in the medial and lateral temporal cortex (Borgwardt et al., 
2008, Pantelis et al., 2003). Likewise, recent work has suggested that neuroimaging-based 
multivariate pattern recognition algorithms, such as the support vector machine, can be 
used to identify ARMS individuals and may have the potential to identify individuals at the 
highest risk of developing psychosis within this population (Koutsouleris et al., 2011). 
Using a region of interest (ROI) approach most of the cross-sectional studies reported gray 
matter volume reductions in the bilateral hippocampus in first-episode (FE) (Adriano et al., 
2011, Phillips et al., 2002) and in chronic schizophrenia (Nelson et al., 1998, Velakoulis et 
al., 2006) when compared to HC.  
There are contradictory results in ARMS: the left HV of individuals with an at-risk mental 
state with transition to psychosis (ARMS-T) was larger than that of the at-risk mental state 
without transition to psychosis (ARMS-NT), but no differences were found between the 
ARMS-T and HC  (Velakoulis et al., 2002), whereas subjects who later became psychotic 
showed reduced gray matter volume in the left parahippocampal gyrus relative to those 
who did not (Mechelli et al., 2011). However, there have also been a number of ROI 
studies which did not find any significant difference between ARMS subjects and HC or 
between ARMS-T and ARMS-NT (Velakoulis et al., 2006, Wood et al., 2005). A recent 
study of our own group comparing HV across ARMS, FE and HC, found the largest HV in 
the ARMS group (Buehlmann et al., 2010), and a meta-analysis of VBM studies of 
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antipsychotic-naïve subjects with an ARMS showed gray matter volume reductions of HV 
suggesting that vulnerability to psychosis is associated with HV decreases (Fusar-Poli et 
al., 2011b). 
There is one longitudinal VBM study of HV in ARMS with transition to psychosis that 
showed most extensive changes in the left medial temporal region with a follow-up period 
of 12 months (Pantelis et al., 2003) and one longitudinal study measuring cortical 
thickness which showed an increased cortical thinning in the left middle temporal gyrus 
over time (Ziermans et al., 2011). 
 
This magnetic resonance imaging (MRI) study aimed to investigate the timing of HV 
changes in ARMS in the early phase of psychosis. To our knowledge there has been no 
ROI based longitudinal study in an antipsychotic-naïve ARMS population. Based on 
previous studies we hypothesized that hippocampal volume reductions are associated with 
an ARMS. Furthermore, we hypothesised a progressive hippocampal volume reduction 
over time in the ARMS-T but not in the ARMS-NT. 
 
Materials and methods 
Participants 
The MRI data were collected as part of a research program (Prediction and early detection 
of schizophrenia – a prospective multilevel approach), that has been described in detail 
elsewhere (Riecher-Rössler et al., 2007, Riecher-Rössler et al., 2009). Subjects with an 
ARMS were recruited through the FePsy-clinic, a specialized clinic for the early detection 
of psychosis at the Department of Psychiatry, University Hospital in Basel, Switzerland. 
Following criteria led to exclusion of the study: history of previous psychotic disorder 
(treated with major tranquilizers for > 3 weeks); symptomatology clearly due to ‘organic’ 
disorder or substance abuse according to ICD-10 criteria (except for cannabis 
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dependency); psychotic symptomatology clearly associated with an affective psychosis or 
a borderline personality disorder; age under 18 years; inadequate knowledge of the German 
language; and IQ less than 70. 
After these exclusion criteria were applied, subjects were assessed using the Basel 
Screening Instrument for Psychosis (BSIP) (Borgwardt et al., 2008), the Brief  Psychiatric 
Rating Scale (BPRS) (Lukoff et al., 1986, Ventura et al., 1993), and the Scale for the 
Assessment of Negative Symptoms (SANS) (Andreasen, 1989).  The BSIP was used to 
evaluate ‘prodromal’ symptoms, defined according to DSM-III-R (American Psychiatric 
Association, 1987), occurring in the last 5 years; non-specific ‘prodromal’ signs (Häfner et 
al., 1991, Riecher et al., 1991) in the last two years; previous or current psychotic 
symptoms; psychosocial functioning over the last 5 years; substance dependency; and 
psychotic disorders among first and second degree relatives (Riecher-Rössler et al., 2006). 
The family history of psychosis was obtained using a semi-structured interview from the 
subject and, whenever possible, a first-degree relative. The frequency of current and 
previous alcohol use was estimated using a semi-structured interview. To assess the 
premorbid IQ we used the MWT, an established measure in German-speaking subjects 
(Lehrl, 1991). 
The antipsychotic-naïve ARMS group (n = 18) was defined using criteria corresponding to 
the Personal Assessment and Crisis Evaluation (PACE) criteria (Phillips et al., 2002, Yung 
et al., 1998) employed also in previous MRI studies of the ARMS  (Borgwardt et al., 2006, 
Borgwardt et al., 2007b, Garner et al., 2005, Pantelis et al., 2003, Phillips et al., 2002, 
Velakoulis et al., 2006). Inclusion thus required one or more of the following: (a) 
“attenuated” psychotic symptoms, (b) brief limited intermittent psychotic symptoms 
(BLIPS), or (c) a first degree relative with a psychotic disorder plus at least two indicators 
of a clinical change, such as a marked decline in social or occupational functioning. 
Inclusion because of “attenuated” psychotic symptoms required scores of 2 or 3 on the 
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hallucination item, 3 or 4 on the unusual thought content or 3 or 4 on the suspiciousness 
items of the BPRS for at least several times a week and persisting for more than 1 week. 
Inclusion because of BLIPS required scores of 4 or above on the hallucination item, or 5 or 
above on the unusual thought content, suspiciousness or conceptual disorganization items 
of the BPRS, with each symptom lasting less than 1 week before resolving spontaneously. 
This ARMS sample overlaps with the sample, which has been investigated in our cross-
sectional study of HVs (Buehlmann et al., 2010).  
After complete description of the study to the subjects, written informed consent was 
obtained. The study was approved by the ethics committee of the University of Basel. 
 
Clinical follow-up and transition to psychosis 
The ARMS subjects were followed up at monthly intervals during the first year, at 3 month 
intervals during the second and third year and annually thereafter until transition to frank 
psychosis or until end of Mai 2007. At each assessment subjects were examined using the 
BPRS. The criteria for transition to psychosis were those defined by Yung (Yung et al., 
1998). In subjects who met these criteria, the diagnosis was determined by a diagnostic 
interview using ICD-10 research criteria at the time of transition, corroborated by a 
subsequent assessment at least one year post transition using the Operational Criteria 
(OPCRIT) checklist for psychotic and affective illness (McGuffin et al., 1991). 
 
Structural MRI 
Image acquisition 
All patients at baseline were scanned using a SIEMENS 1.5 T scanner at the University 
Hospital Basel. The first scan was conducted at study intake. Head movement was 
minimised by foam padding and velcro straps across the forehead and chin. A three-
dimensional volumetric spoiled gradient recalled echo sequence generated 170-176 
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contiguous, 1-mm thick sagittal slices. Imaging parameters were: time-to-echo, 3.04-4 ms; 
time-to-repetition, 1.9-9.7 ms; flip angle, 12-15; matrix size, 200 × 256; field of view, 25.6 
× 25.6 cm matrix; voxel dimensions, 1 × 1 × 1 mm. 
 
Image analysis 
Original DICOM data were then converted to Analyze 7.5 format in axial direction coded 
to ensure blindness of the investigator and patients' confidentiality and finally imported 
into the image-analysis software AMIRA (Kappos et al., 2006). The boundaries of the 
hippocampus were identified including the subiculum, cornu ammonis (hippocampus 
proper), and the dentate gyrus. The amygdala was excluded. The regions of interest were 
defined on the coronal and sagittal slices, and finally checked on the coronal plane again. 
Anterior segmentation was achieved by tracing on sagittal slices. The hippocampal volume 
was traced generally following the protocol of Jack et al. (1989), which has been used by 
our group before (Buehlmann et al., 2010).  All measurements were carried out by a 
trained and blinded rater (AW). The intra-rater intra-class correlation coefficient at 
baseline (n = 18) was 0.89 and 0.77 for the right and left HV, respectively, when using 
manual segmentation in all baseline MRIs that were measured twice within three weeks.  
The whole brain volume (WBV) was measured to correct for differences in head size as 
previously described (Borgwardt et al., 2007a, Borgwardt et al., 2007b, Haller et al., 2009) 
 
Statistical analysis 
Statistical Analyses were performed using the R environment for statistical (R 
Development Core Team, 2012). Clinical and demographic differences between groups 
were examined with Fisher’s exact test and Welch’s two-sample t-test. HV changes over 
time were analyzed by using a linear mixed effects model that included a random intercept 
factor for the subjects and fixed effects for time, hemisphere, age, medication, WBV (at 
 10
baseline) and time by hemisphere interaction. Due to the small sample size, significance 
tests of the fixed effects parameters in linear mixed effects models were based on 10,000 
Markov Chain Monte Carlo (MCMC) simulations using the pvals.fnc function in 
the languageR package (Baayen, 2011). 
 
Results 
 
Demographic and clinical data 
During follow-up, 8 out of 18 ARMS individuals made the transition to psychosis (ARMS-
T) and 10 did not (ARMS-NT). Those subjects who developed psychosis during the 
follow-up period were scanned again after its onset (1178 ± 501 days). The other subjects 
were scanned at the end of the follow-up period (1541 ± 224 days) (Table 1). 
 
INSERT TABLE 1 HERE 
 
There were no significant differences between ARMS-T and ARMS-NT regarding sex, 
age, education at baseline, and interscan-interval. There was a trend towards higher BPRS 
and SANS scores at baseline in ARMS-T compared to the ARMS-NT (Table 1). All 
patients were antipsychotic-naïve at the time of baseline. At the time of follow-up scan, 5 
of the ARMS-T patients were treated with antipsychotics (three with olanzapine, one with 
risperidone, one with perphenazine) because these patients had to be treated for clinical 
and ethical reasons. The time lag between the transition and the second scan was 988 days 
on average. All ARMS-NT subjects were still antipsychotic-naïve at follow-up. 
 
Hippocampal volume change during follow-up 
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There was a significant negative main effect of time (p < 0.05) but no significant time by 
hemisphere interaction, suggesting that HV decreased over time in the combined ARMS-T 
+ ARMS-NT sample and that HV changes across time did not differ between hemispheres.  
A model that additionally included group (ARMS-T vs. ARMS-NT) and the time by group 
interaction as independent variables did not reveal statistically significant group and group 
by time interaction effects, i.e. no differences between ARMS-T and ARMS-NT subjects 
Table 2, Figure 1). 
 
INSERT TABLE 2 AND FIGURE 1 HERE 
 
Effects of whole brain volume, age, hemisphere, and antipsychotics on HV 
We found a significant effect of WBV (p = 0.0004) but no effect of age on HV. We did not 
consider gender as a fixed effect because we found a strong effect of WBV on HV and 
adding sex as a fixed effect did not change our results. There was a trend for smaller HV 
on the left side compared to the right side (p < 0.1). The mixed effects model revealed that 
– independent of time and all other covariates in the model – antipsychotic medication, 
which was present in 5 ARMS-T patients at the second scan, was associated with increased 
HV (p < 0.05). 
 
Correlational analyses with clinical psychopathology 
In a next step, we tested whether HV was associated with the severity of 
psychopathological symptoms. We found no significant correlation between HV and 
SANS or BPRS at baseline. These results also did not change when we corrected for 
WBV. 
 
Discussion 
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Our first hypothesis that ARMS group as a whole would show progressive hippocampal 
volume reduction was confirmed. We found a reduction of manually traced HV over time 
in antipsychotic-naïve ARMS, independently of clinical outcome. Interestingly, we found 
that medication with antipsychotics in the ARMS-T after transition to psychosis was 
associated with larger HV. 
Our results are in line with a previous longitudinal VBM study in ARMS with transition to 
psychosis giving evidence for progressive gray-matter volume reduction in the left medial 
temporal lobe over a follow-up period 12 months (Borgwardt et al., 2008, Pantelis et al., 
2003). Likewise, Ziermans et al. (2011) demonstrated an increased cortical thinning in the 
left middle temporal gyrus in an adolescent ARMS groups over a follow-up period of 2 
years. Our findings support studies that suggest that hippocampal volume reduction is a 
marker of illness rather than a marker of risk (Velakoulis et al., 2006).  
Currently, the stress-vulnerability model is commonly accepted in psychotic disorders (van 
Os et al., 2010). The decrease of HV might reflect hippocampal sensitivity to stress due to 
the fact that being in an ARMS is accompanied by a higher level of stress, and the 
vulnerability of the hippocampus to various hormones induced by stressful experiences has 
been demonstrated (McEwen, 1999). The most likely mechanism by which stress 
suppresses adult neurogenesis in the hippocampus is via activation of the hypothalamic–
pituitary–adrenal (HPA) axis and subsequent elevation of glucocorticoid levels (Phillips et 
al., 2006). Furthermore the hippocampus itself dampens the activity of HPA axis, so 
impaired functioning of the hippocampus could lead to further activation of the HPA axis 
and to elevated levels of cortisol. A cross-sectional study found no relationship between 
plasma cortisol levels and HVs (Thompson et al. 2007). 
Contrary to our second hypothesis, we were not able to demonstrate a progressive decrease 
of HV in ARMS-T compared to ARMS-NT. This is in line with an own VBM study 
(Borgwardt et al., 2008) and previous ROI studies that found normal hippocampal volumes 
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in patients with first-episode psychosis and no differences between the ARMS-T and HC 
(Velakoulis et al., 2006). Our results might be due to fact that we did not split the patients 
with transition to psychosis into subgroups that potentially differ in their HV reduction.  
We report no difference in HVs between ARMS-T and ARMS-NT which has been shown 
in two previous large volumetric MRI studies (Velakoulis et al., 2006, Wood et al., 2005) 
and also in a small sample by our own group (Bühlmann et al. 2009). There is only one 
early cross-sectional study with contradictory results which reported smaller HVs in 
ARMS-T compared to ARMS-NT (Phillips et al., 2002) and differing results may be 
explained by the smaller sample size. 
Our finding of a left laterality of hippocampus is consistent with previous neuroimaging 
reports from a sample of which the here presented sample is part of (Buehlmann et al., 
2010) and is in line with most (Velakoulis et al., 1999, Velakoulis et al., 2006), but not all 
previous studies (Hurlemann et al., 2008).  
There are many mechanisms that can lead to medial temporal volume changes including 
medication use. Thus, another explanation might be that progressive HV decrease in 
ARMS-T is masked by the enlarging effect of antipsychotics, which were only present in 
the ARMS-T group at the time of the second scan (Borgwardt et al., 2010). The here 
presented data suggest that antipsychotic medication may reduce hippocampal volume 
loss. Certainly, the observed medication effect must be interpreted with caution because it 
is only based on five patients. Reduced HV loss has been shown for first generation 
antipsychotics (Lieberman et al., 2001) or for both first and second generation 
antipsychotics (Wood et al., 2001), including quetiapine in preclinical studies (Bi et al., 
2009, Park et al., 2006). Due to the small sample size and because 4 out of 5 patients were 
treated with atypical antipsychotics, we could not differentiate typical from atypical 
antipsychotics. However, comparing treatment with haloperidol to clozapine, there was no 
difference in hippocampal volume (Arango et al., 2003) and data regarding the effects of 
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typical and atypical antipsychotic medications in general on hippocampal volume are 
equivocal (Velakoulis et al., 2006). 
Contrary to that, atypical antipsychotics showed significant increase in left hippocampal 
volume as compared to the typical antipsychotics (McClure et al., 2006) and atypical 
antipsychotics rather than haloperidol may protect against hippocampal volume reduction 
(Chakos et al., 2005). Consistently, schizophrenia patients treated with antipsychotics 
showed gray matter volumetric reductions in medial temporal regions (Smieskova et al., 
2009) and has been demonstrated in a large longitudinal study (Ho et al., 2011), but to 
differentiate the contribution of the medication and the psychosis itself was not clearly 
possible. 
The presented study is the second longitudinal study regarding HV in ARMS and the first 
with a follow-up period beyond 12 months. With an average follow-up duration of 
approximately five years, we can be quite sure that we did not miss a transition to 
psychosis because transition to psychosis is likely to happen within the first three years of 
clinical presentation (Fusar-Poli et al., 2012a).  
 
We did not find a correlation between psychopathology and hippocampal volume which is 
in contrast to other results, which showed significant inverse correlations between left 
hippocampus and negative symptoms, and left anterior and posterior hippocampus 
volumes and positive and negative symptoms, respectively (Rajarethinam et al., 2001). 
Another group also demonstrated significant correlation between reduced scores on 
neuropsychological measures of declarative-episodic memory and reduced hippocampal 
volumes (Kuroki et al., 2006). 
The lack of significant differences between ARMS-T and ARMS-NT in the present study 
may be driven by the relatively small sample size of this high risk population, which is 
very difficult to collect and to follow up on. Moreover, ARMS individuals may present 
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with other non-psychotic features such as anxiety and depression that might also contribute 
to enhance the heterogeneity within the group leading to limited statistical power.   
Furthermore, we did not quantify cumulative medication with antipsychotics or for other 
medication than antipsychotics even though several of our ARMS patients who had 
additionally depressive symptoms were treated with antidepressants, and a stimulation of 
neurogenesis in the hippocampus by antidepressants has been suggested by others 
(Krishnan and Nestler, 2008, Santarelli et al., 2003). Moreover, an antipsychotic effect of 
antidepressants by improving mood, reducing the faulty appraisal of prodromal symptoms, 
and modulating the individual's response to environmental stressors has been hypothesized 
(Fusar-Poli et al., 2007b). 
 
Conclusions 
This is the first longitudinal long-term MRI study of hippocampal volume in antipsychotic-
naïve ARMS patients suggesting a role of reduced HV in early psychosis.  
Our findings suggest that hippocampal volume alterations accumulate during the transition 
to psychosis potentially allowing for the accurate early recognition of individuals at risk of 
developing psychosis. 
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Table 1. Sociodemographic and Clinical Sample description by group 
 
  
ARMS-NT (n = 10, 
w/m = 5/5) 
 
 
ARMS-T (n = 8, 
w/m = 8/2) 
 
p 
 
 
Age at baseline scan (years) 
 
25.54 (6.00) 
 
25.83 (7.56) 
 
0.72 
 
Education (years) 
 
11.60 (3.43)  
 
10.69 (1.65) 
 
0.7132 
 
BPRS total score at baseline  
 
36.20 (4.78) 
 
43.88 (10.18) 
 
0.0792 
 
SANS total score at baseline 
 
13.62 (10.82) 
 
34.32 (26.58) 
 
0.0692 
 
Inter-scan interval t0-tx (days) 
 
1541 (224)  
 
1178 (501) 
 
0.0892 
 
Time between transition and 
2nd scan (days) 
 
 
- 
 
988 (688) 
 
Data are mean (SD) unless otherwise stated. 
SANS = Scale for the Assessment of Negative Symptoms (Andreasen, 1989); BPRS = 
Brief Psychiatric Rating Scale (Lukoff et al., 1986). 
1Fisher’s Exact test 
2Welch Two Sample t test 
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Table 2. Hippocampal and Whole Brain Volume by Group HV 
 
   
ARMS-NT  
(n = 10) 
 
ARMS-T  
(n = 8) 
 
p 
Baseline Right HV 3.062 (0.43)  3.060 (0.284) 0.9921 
Left HV 2.934 (0.444)  2.906 (0.354) 0.8861 
Whole brain volume 1310 (122) 1318 (112) 0.8831 
Follow-up Right HV 2.837 (0.346) 2.858 (0.460) 0.9191 
Left HV 2.794 (0.442) 2.754 (0.335) 0.8291 
Whole brain volume 1264 (122) 1281 (106) 0.7561 
Data are presented as mean ml (SD). 
1Welch Two Sample t test 
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Figure 1. Volume changes of the hippocampus (left and right side) in patients with an 
ARMS without transition (ARMS-NT) and with transition to psychosis (ARMS-T). 
 
 
Values of baseline and follow-up scans in each subject are connected with a straight line. 
The thick red lines are the model predicted hippocampus volumes for different time points, 
patients groups, and hemispheres, when the other covariates are held at their mean values. 
 
